Skip to main content
Erschienen in: Social Psychiatry and Psychiatric Epidemiology 9/2009

01.09.2009 | ORIGINAL PAPER

First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group

verfasst von: Kathleen Crebbin, Emma Mitford, Roger Paxton, Douglas Turkington

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Little is known about first-episode drug-induced psychosis (F19.5).

Objectives

To examine the incidence, course, diagnostic stability, and outcomes of first-episode drug-induced psychosis (F19.5), and compare with first-episode schizophrenia (F20–21).

Method

An observational database was set up on all patients aged 16 and over with a first episode psychosis living in a county in Northern England between October 1998 and October 2005. Data were collected at presentation and annual follow-up. Information on patients with an ICD-10 diagnosis of either drug-induced psychosis (F19.5) or schizophrenia (F20) was compared.

Results

There was no significant difference between the two groups in levels of hospitalisation and violence. Patients with a drug-induced psychosis were more likely to lose contact with services, and a third developed a schizophrenia-spectrum disorder.

Conclusions

Increased attention should be paid to maintaining engagement with this high-risk group who have a high rate of transition to schizophrenia.
Literatur
1.
Zurück zum Zitat Addington J, Addington D (1997) Cognitive and social functioning in schizophrenia out-patients who abuse substances. J Psychiatry Neurosci 22:99–104PubMed Addington J, Addington D (1997) Cognitive and social functioning in schizophrenia out-patients who abuse substances. J Psychiatry Neurosci 22:99–104PubMed
2.
Zurück zum Zitat Arendt M, Munk-Jørgensen P (2004) Heavy cannabis users seeking treatment, prevalence of psychiatric disorders. Soc Psychiatry Psychiatr Epidemiol 39:97–105PubMedCrossRef Arendt M, Munk-Jørgensen P (2004) Heavy cannabis users seeking treatment, prevalence of psychiatric disorders. Soc Psychiatry Psychiatr Epidemiol 39:97–105PubMedCrossRef
3.
Zurück zum Zitat Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jørgensen P (2005) Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. Br J Psychiatry 187:510–515PubMedCrossRef Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jørgensen P (2005) Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. Br J Psychiatry 187:510–515PubMedCrossRef
4.
Zurück zum Zitat Arseneault L, Cannon M, Witton J, Murray RM (2004) Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184:110–117PubMedCrossRef Arseneault L, Cannon M, Witton J, Murray RM (2004) Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184:110–117PubMedCrossRef
5.
Zurück zum Zitat Barnes TRE, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM (2006) Comorbid substance use and age of onset of schizophrenia. Br J Psychiatry 188:237–242PubMedCrossRef Barnes TRE, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM (2006) Comorbid substance use and age of onset of schizophrenia. Br J Psychiatry 188:237–242PubMedCrossRef
6.
Zurück zum Zitat Craig TKJ, Garety P, Power P, Rahaman N, Colbert S, Fornells-Ambrojo M et al (2004) The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ doi: 10.1136/bmj.38246.594873.7C (published online 14 October 2004) Craig TKJ, Garety P, Power P, Rahaman N, Colbert S, Fornells-Ambrojo M et al (2004) The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ doi: 10.​1136/​bmj.​38246.​594873.​7C (published online 14 October 2004)
7.
Zurück zum Zitat Drake RE, Osher FC, Wallach MA (1989) Alcohol use and abuse in schizophrenia. J Nerv Ment Dis 17:408–414 Drake RE, Osher FC, Wallach MA (1989) Alcohol use and abuse in schizophrenia. J Nerv Ment Dis 17:408–414
8.
Zurück zum Zitat Hides L, Dawe S, Kavanagh DJ, Young RM (2006) Psychotic symptom and cannabis relapse in recent-onset psychosis. Br J Psychiatry 189:137–143PubMedCrossRef Hides L, Dawe S, Kavanagh DJ, Young RM (2006) Psychotic symptom and cannabis relapse in recent-onset psychosis. Br J Psychiatry 189:137–143PubMedCrossRef
9.
Zurück zum Zitat Johns LC, Cannon M, Singleton N, Murray RM, Farrell M, Brugha T et al (2004) Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry 185:298–305PubMedCrossRef Johns LC, Cannon M, Singleton N, Murray RM, Farrell M, Brugha T et al (2004) Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry 185:298–305PubMedCrossRef
10.
Zurück zum Zitat Kavanagh DJ, Waghorn G, Jenner L, Chant DC, Carr V, Evans M et al (2004) Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res 66:115–124PubMedCrossRef Kavanagh DJ, Waghorn G, Jenner L, Chant DC, Carr V, Evans M et al (2004) Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res 66:115–124PubMedCrossRef
11.
Zurück zum Zitat Kendrick T, Burns T, Garland C et al (2000) Are specialist mental health services being targeted on the most needy patients? The effects of setting up special services in general practice. Br J Gen Pract 50:121–126PubMed Kendrick T, Burns T, Garland C et al (2000) Are specialist mental health services being targeted on the most needy patients? The effects of setting up special services in general practice. Br J Gen Pract 50:121–126PubMed
12.
Zurück zum Zitat Killaspy H, Banerjee S, King M, Lloyd M (2000) Prospective controlled study of psychiatry out-patient non-attendance. Br J Psychiatry 176:160–165PubMedCrossRef Killaspy H, Banerjee S, King M, Lloyd M (2000) Prospective controlled study of psychiatry out-patient non-attendance. Br J Psychiatry 176:160–165PubMedCrossRef
13.
Zurück zum Zitat Menezes PR, Johnson S, Thornicroft G, Marshall J, Prosser D, Bebbington P et al (1996) Drug and alcohol problems among individuals with severe mental illness in south London. Br J Psychiatry 168:612–619PubMedCrossRef Menezes PR, Johnson S, Thornicroft G, Marshall J, Prosser D, Bebbington P et al (1996) Drug and alcohol problems among individuals with severe mental illness in south London. Br J Psychiatry 168:612–619PubMedCrossRef
14.
Zurück zum Zitat Owen RR, Fischer EP, Booth BM, Cuffel BJ (1996) Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv 47(8):853–858PubMed Owen RR, Fischer EP, Booth BM, Cuffel BJ (1996) Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv 47(8):853–858PubMed
15.
Zurück zum Zitat Perkonigg A, Settele A, Pfister H, Hoffler M, Frohlich C, Zimmermann P, Lieb R, Vittchen H (2006) Where have they been? Service use of regular substance users with and without abuse and dependence. Soc Psychiatry Psychiatr Epidemiol 41:470–479PubMedCrossRef Perkonigg A, Settele A, Pfister H, Hoffler M, Frohlich C, Zimmermann P, Lieb R, Vittchen H (2006) Where have they been? Service use of regular substance users with and without abuse and dependence. Soc Psychiatry Psychiatr Epidemiol 41:470–479PubMedCrossRef
16.
Zurück zum Zitat Proctor SE, Mitford E, Paxton R (2004) First episode psychosis: a novel methodology reveals higher than expected incidence; a reality-based population profile in Northumberland, UK. J Eval Clin Pract 10(4):539–547PubMedCrossRef Proctor SE, Mitford E, Paxton R (2004) First episode psychosis: a novel methodology reveals higher than expected incidence; a reality-based population profile in Northumberland, UK. J Eval Clin Pract 10(4):539–547PubMedCrossRef
17.
Zurück zum Zitat Sevy S, Robinson DG, Solloway S, Alvir JM, Woerner MG, Bilder R et al (2001) Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatr Scand 104:367–374PubMedCrossRef Sevy S, Robinson DG, Solloway S, Alvir JM, Woerner MG, Bilder R et al (2001) Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatr Scand 104:367–374PubMedCrossRef
18.
Zurück zum Zitat Smyth M, Vostanis P (1990) Psychiatric out-patient non-attenders: a cause for relief or concern? Psychiatr Bull 14:147–149CrossRef Smyth M, Vostanis P (1990) Psychiatric out-patient non-attenders: a cause for relief or concern? Psychiatr Bull 14:147–149CrossRef
19.
Zurück zum Zitat Soyka M (2000) Substance misuse, psychiatric disorder and violent and disturbed behaviour. Br J Psychiatry 176:345–350PubMedCrossRef Soyka M (2000) Substance misuse, psychiatric disorder and violent and disturbed behaviour. Br J Psychiatry 176:345–350PubMedCrossRef
20.
Zurück zum Zitat Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, Wagner HR, Rosenheck RA et al (2006) A national study of violent behaviour in persons with schizophrenia. Arch Gen Psychiatry 63:490–499PubMedCrossRef Swanson JW, Swartz MS, Van Dorn RA, Elbogen EB, Wagner HR, Rosenheck RA et al (2006) A national study of violent behaviour in persons with schizophrenia. Arch Gen Psychiatry 63:490–499PubMedCrossRef
21.
Zurück zum Zitat Thornicroft G (1990) Cannabis and psychosis: is there epidemiological evidence for an association. Br J Psychiatry 157:25–33PubMedCrossRef Thornicroft G (1990) Cannabis and psychosis: is there epidemiological evidence for an association. Br J Psychiatry 157:25–33PubMedCrossRef
22.
Zurück zum Zitat Van Mastrigt S, Addington J, Addington D (2004) Substance misuse at presentation to an early psychosis program. Soc Psychiatry Psychiatr Epidemiol 39:69–72PubMedCrossRef Van Mastrigt S, Addington J, Addington D (2004) Substance misuse at presentation to an early psychosis program. Soc Psychiatry Psychiatr Epidemiol 39:69–72PubMedCrossRef
23.
Zurück zum Zitat Verdoux H (2004) Cannabis and psychosis proneness. In: Castle D, Murray R (eds) Marihuana and madness. Cambridge University Press, Cambridge, pp 75–88 Verdoux H (2004) Cannabis and psychosis proneness. In: Castle D, Murray R (eds) Marihuana and madness. Cambridge University Press, Cambridge, pp 75–88
24.
Zurück zum Zitat Wade D, Harrigan S, Burgess PM, Whelan G, McGorry PD (2006) Substance misuse in first-episode psychosis: a 15-month prospective follow-up study. Br J Psychiatry 189:29–234CrossRef Wade D, Harrigan S, Burgess PM, Whelan G, McGorry PD (2006) Substance misuse in first-episode psychosis: a 15-month prospective follow-up study. Br J Psychiatry 189:29–234CrossRef
25.
Zurück zum Zitat Walsh E, Buchanan A, Fahy T (2002) Violence and schizophrenia: examining the evidence. Br J Psychiatry 180:490–495PubMedCrossRef Walsh E, Buchanan A, Fahy T (2002) Violence and schizophrenia: examining the evidence. Br J Psychiatry 180:490–495PubMedCrossRef
26.
Zurück zum Zitat Whitwell D (2001) Early intervention as a core task for general psychiatry. Psychiatr Bull 25:146–148CrossRef Whitwell D (2001) Early intervention as a core task for general psychiatry. Psychiatr Bull 25:146–148CrossRef
27.
Zurück zum Zitat Young A, Grusky O, Jordan D, Belin TR (2000) Routine outcome monitoring in a public mental health system: the impact of patients who leave care. Psychiatr Serv 51:85–91PubMed Young A, Grusky O, Jordan D, Belin TR (2000) Routine outcome monitoring in a public mental health system: the impact of patients who leave care. Psychiatr Serv 51:85–91PubMed
Metadaten
Titel
First-episode drug-induced psychosis: a medium term follow up study reveals a high-risk group
verfasst von
Kathleen Crebbin
Emma Mitford
Roger Paxton
Douglas Turkington
Publikationsdatum
01.09.2009
Erschienen in
Social Psychiatry and Psychiatric Epidemiology / Ausgabe 9/2009
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-008-0490-2

Weitere Artikel der Ausgabe 9/2009

Social Psychiatry and Psychiatric Epidemiology 9/2009 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.